Cancer Biology and Therapy

Edit Your Profile

Cancer Biology and Therapy Journal

publication venue for

Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer. 14:557-563. 2013
Combinatorial library discovery of small molecule inhibitors of lung cancer proliferation and parathyroid hormone-related protein expression. 10:1068-1076. 2010
Circulating cell-free DNA - A novel biomarker for response to therapy in ovarian carcinoma. 5:1369-1374. 2006
The role of relaxin in endometrial cancer. 5:71-77. 2006

category

ONCOLOGY Category

International Standard Serial Number (ISSN)

1538-4047